サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1380291

単球活性化試験市場：製品、供給源、用途、エンドユーザー別-2023～2030年の世界予測

Monocyte Activation Tests Market by Product (Monocyte Activation Test Kits, Reagents), Source (Cell Line-based, PBMC-based), Application, End-user - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
単球活性化試験市場：製品、供給源、用途、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

単球活性化試験市場は、2022年の5億5,143万米ドルから2030年には8億4,146万米ドルに達すると予測され、予測期間中のCAGRは5.42%です。

単球活性化試験の世界市場

主な市場の統計
市場金額：基準年[2022年] 5億5,143万米ドル
推定市場金額[2023年] 5億8,882万米ドル
予測市場金額[2030年] 8億4,146万米ドル
CAGR（%） 5.42%
単球活性化試験 Market-IMG1

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは単球活性化試験市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。洞察により、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.単球活性化試験市場の市場規模および予測は？

2.単球活性化試験市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.単球活性化試験市場における競争戦略枠組みとは？

4.単球活性化試験市場の最新技術動向と規制枠組みは？

5.単球活性化試験市場における主要ベンダーの市場シェアは？

6.単球活性化試験市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 患者の安全に対する重要性の高まりと、安全でより信頼性の高いパイロジェン検査への需要
      • 動物ベースの体外代替療法への取り組みの拡大
      • 民間および公的部門による製薬分野への投資の増加
    • 抑制要因
      • 単球活性化試験キットと試薬の資本集約的な開発プロセス
    • 機会
      • 新開発の単球活性化試験キットを発売
      • 各国の医療インフラと支出の増加
    • 課題
      • 単球活性化試験キットおよび試薬の承認に関連する厳しい規制のハードル
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 単球活性化試験市場：製品別

  • イントロダクション
  • 単球活性化テストキット
  • 試薬

第7章 単球活性化試験市場：供給源別

  • イントロダクション
  • 細胞株ベース
  • PBMCベース

第8章 単球活性化試験市場：用途別

  • イントロダクション
  • 医薬品開発
  • 医療機器検査
  • ワクチン開発

第9章 単球活性化試験市場：エンドユーザー別

  • イントロダクション
  • バイオテクノロジー企業
  • 医療機器メーカー
  • 製薬メーカー

第10章 南北アメリカの単球活性化試験市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋の単球活性化試験市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの単球活性化試験市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競合ポートフォリオ

  • 主要な企業プロファイル
    • Becton, Dickinson and Company
    • CellMade Laboratories
    • Charles River Laboratories International, Inc
    • Eurofins Scientific SE
    • GenScript Biotech Corporation
    • Lonza Group Ltd.
    • Lps-Biosciences
    • 単球活性化試験 BioTech BV
    • Merck KGaA
    • Microcoat Biotechnologie GmbH
    • Nelson Laboratories, LLC by Sotera Health Company
    • SOLVIAS AG
    • Thermo Fisher Scientific Inc.
    • Wickham Micro Limited
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MONOCYTE ACTIVATION TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. MONOCYTE ACTIVATION TESTS MARKET DYNAMICS
  • FIGURE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MONOCYTE ACTIVATION TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MONOCYTE ACTIVATION TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY CELL LINE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PBMC-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICES TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. MONOCYTE ACTIVATION TESTS MARKET LICENSE & PRICING
目次
Product Code: MRR-69324464D094

The Monocyte Activation Tests Market is projected to reach USD 841.46 million by 2030 from USD 551.43 million in 2022, at a CAGR of 5.42% during the forecast period.

Global Monocyte Activation Tests Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 551.43 million
Estimated Year Value [2023] USD 588.82 million
Forecast Year Value [2030] USD 841.46 million
CAGR (%) 5.42%
Monocyte Activation Tests Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Monocyte Activation Tests Market.

Based on Product, market is studied across Monocyte Activation Test Kits and Reagents. The Reagents is projected to witness significant market share during forecast period.

Based on Source, market is studied across Cell Line-based and PBMC-based. The PBMC-based is projected to witness significant market share during forecast period.

Based on Application, market is studied across Drug Development, Medical devices Testing, and Vaccine Development. The Vaccine Development is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Biotechnology Companies, Medical Device Manufacturers, and Pharmaceutical Manufacturers. The Pharmaceutical Manufacturers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Monocyte Activation Tests Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Monocyte Activation Tests Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Monocyte Activation Tests Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, CellMade Laboratories, Charles River Laboratories International, Inc, Eurofins Scientific SE, GenScript Biotech Corporation, Lonza Group Ltd., Lps-Biosciences, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories, LLC by Sotera Health Company, SOLVIAS AG, Thermo Fisher Scientific Inc., and Wickham Micro Limited.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Monocyte Activation Tests Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Monocyte Activation Tests Market?

3. What is the competitive strategic window for identifying opportunities in the Monocyte Activation Tests Market?

4. What are the latest technology trends and regulatory frameworks in the Monocyte Activation Tests Market?

5. What is the market share of the leading vendors in the Monocyte Activation Tests Market?

6. Which modes and strategic moves are suitable for entering the Monocyte Activation Tests Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Monocyte Activation Tests Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising emphasis on patient safety and demand for safe and more reliable pyrogen testing
      • 5.1.1.2. Growing initiatives for animal-based in-vitro alternatives
      • 5.1.1.3. Increasing investments in the pharmaceutical sector by private and public sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive development process of MAT kits and reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Launch of newly developed monocyte activation test kits
      • 5.1.3.2. Rising healthcare infrastructure and spending across economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory hurdles associated with approval of MAT kits and reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Monocyte Activation Tests Market, by Product

  • 6.1. Introduction
  • 6.2. Monocyte Activation Test Kits
  • 6.3. Reagents

7. Monocyte Activation Tests Market, by Source

  • 7.1. Introduction
  • 7.2. Cell Line-based
  • 7.3. PBMC-based

8. Monocyte Activation Tests Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Development
  • 8.3. Medical devices Testing
  • 8.4. Vaccine Development

9. Monocyte Activation Tests Market, by End-user

  • 9.1. Introduction
  • 9.2. Biotechnology Companies
  • 9.3. Medical Device Manufacturers
  • 9.4. Pharmaceutical Manufacturers

10. Americas Monocyte Activation Tests Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Monocyte Activation Tests Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Monocyte Activation Tests Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Becton, Dickinson and Company
    • 14.1.2. CellMade Laboratories
    • 14.1.3. Charles River Laboratories International, Inc
    • 14.1.4. Eurofins Scientific SE
    • 14.1.5. GenScript Biotech Corporation
    • 14.1.6. Lonza Group Ltd.
    • 14.1.7. Lps-Biosciences
    • 14.1.8. MAT BioTech BV
    • 14.1.9. Merck KGaA
    • 14.1.10. Microcoat Biotechnologie GmbH
    • 14.1.11. Nelson Laboratories, LLC by Sotera Health Company
    • 14.1.12. SOLVIAS AG
    • 14.1.13. Thermo Fisher Scientific Inc.
    • 14.1.14. Wickham Micro Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing